Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 5:21 PM View:  | Ek John Frederick CFO | Akoya Biosciences, Inc. (AKYA) | 19-Nov-24 | Grant | 87,500 | -- | -- | 44% 200.73K to 288.23K | |
| Yesterday 5:20 PM View: | Bamford Pascal Chief Clinical Officer | Akoya Biosciences, Inc. (AKYA) | 19-Nov-24 | Grant | 87,500 | -- | -- | 71% 122.76K to 210.26K | |
| Yesterday 5:22 PM View: | Kamocsay Jennifer Chief Legal Officer | Akoya Biosciences, Inc. (AKYA) | 19-Nov-24 | Grant | 87,500 | -- | -- | 88% 99.22K to 186.72K | |
| 03-Sep-24 9:41 PM View: | Bamford Pascal Chief Clinical Officer | Akoya Biosciences, Inc. (AKYA) | 29-Aug-24 | Grant | 40,000 | -- | -- | 48% 82.76K to 122.76K | |
| 12-Jun-24 4:01 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 11-Jun-24 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 3% 224.73K to 232.23K | |
| 12-Jun-24 4:01 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 11-Jun-24 | Planned Option Sale | 7,500 | $2.08 | $15,630.00 | (3%) 232.23K to 224.73K | |
| 07-Jun-24 9:56 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 06-Jun-24 | Planned Option Sale | 7,500 | $2.01 | $15,063.80 | (3%) 232.23K to 224.73K | |
| 07-Jun-24 9:56 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 06-Jun-24 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 3% 224.73K to 232.23K | |
| 02-Apr-24 4:41 PM View: | Ek John Frederick CFO | Akoya Biosciences, Inc. (AKYA) | 01-Apr-24 | Payment of Exercise | 14,272 | $4.56 | $65,080.30 | (7%) 215.0K to 200.73K | |
| 25-Mar-24 5:14 PM View: | Ramachandran Niro Ph.D Chief Business Officer | Akoya Biosciences, Inc. (AKYA) | 23-Mar-24 | Payment of Exercise | 2,006 | $4.79 | $9,608.74 | (< 1%) 209.93K to 207.92K | |
| 25-Mar-24 5:12 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 23-Mar-24 | Payment of Exercise | 7,135 | $4.79 | $34,176.60 | (3%) 231.87K to 224.73K | |
| 25-Mar-24 5:16 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 23-Mar-24 | Payment of Exercise | 2,006 | $4.79 | $9,608.74 | (2%) 123.51K to 121.5K | |
| 22-Mar-24 5:54 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 20-Mar-24 | Planned Option Sale | 7,500 | $4.97 | $37,242.80 | (3%) 239.37K to 231.87K | |
| 22-Mar-24 5:54 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 20-Mar-24 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 3% 231.87K to 239.37K | |
| 14-Mar-24 8:41 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 13-Mar-24 | Sale (Planned) | 7,500 | $4.94 | $37,035.00 | (3%) 231.87K to 224.37K | |
| 14-Mar-24 8:40 PM View: | Shepler Robert G Director | Akoya Biosciences, Inc. (AKYA) | 13-Mar-24 | Gift | 369,592 | -- | -- | 100% 369.59K to 739.18K | |
| 14-Mar-24 8:40 PM View: | Shepler Robert G Director | Akoya Biosciences, Inc. (AKYA) | 13-Mar-24 | Gift | 369,592 | -- | -- | (50%) 739.18K to 369.59K | |
| 01-Mar-24 9:21 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 01-Mar-24 | Payment of Exercise | 10,244 | $6.03 | $61,771.30 | (9%) 113.75K to 103.51K | |
| 01-Mar-24 9:52 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 01-Mar-24 | Payment of Exercise | 2,049 | $6.03 | $12,355.50 | (2%) 125.56K to 123.51K | |
| 01-Mar-24 9:53 PM View: | Kamocsay Jennifer General Counsel | Akoya Biosciences, Inc. (AKYA) | 01-Mar-24 | Payment of Exercise | 3,283 | $6.03 | $19,796.50 | (3%) 102.5K to 99.22K | |
| 01-Mar-24 9:52 PM View: | Ramachandran Niro Ph.D Chief Business Officer | Akoya Biosciences, Inc. (AKYA) | 01-Mar-24 | Payment of Exercise | 2,305 | $6.03 | $13,899.20 | (1%) 212.24K to 209.93K | |
| 01-Mar-24 9:52 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 22-Feb-24 | Grant | 35,000 | -- | -- | 39% 90.56K to 125.56K | |
| 01-Mar-24 9:53 PM View: | Kamocsay Jennifer General Counsel | Akoya Biosciences, Inc. (AKYA) | 22-Feb-24 | Grant | 35,000 | -- | -- | 52% 67.5K to 102.5K | |
| 01-Mar-24 9:52 PM View: | Ramachandran Niro Ph.D Chief Business Officer | Akoya Biosciences, Inc. (AKYA) | 22-Feb-24 | Grant | 35,000 | -- | -- | 20% 177.24K to 212.24K | |
| 01-Mar-24 9:58 PM View: | Ek John Frederick CFO | Akoya Biosciences, Inc. (AKYA) | 22-Feb-24 | Grant | 35,000 | -- | -- | 19% 180.0K to 215.0K | |
| 01-Mar-24 9:21 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 22-Feb-24 | Grant | 87,500 | -- | -- | 57% 152.56K to 240.06K | |
| 20-Dec-23 7:16 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 19-Dec-23 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 5% 152.56K to 160.06K | |
| 20-Dec-23 7:16 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 19-Dec-23 | Planned Option Sale | 7,500 | $4.48 | $33,565.50 | (5%) 160.06K to 152.56K | |
| 14-Dec-23 4:24 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 12-Dec-23 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 5% 152.56K to 160.06K | |
| 14-Dec-23 4:24 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 12-Dec-23 | Planned Option Sale | 7,500 | $4.25 | $31,871.20 | (5%) 160.06K to 152.56K | |
| 22-Nov-23 4:00 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 20-Nov-23 | Planned Option Sale | 7,500 | $4.39 | $32,901.00 | (5%) 160.06K to 152.56K | |
| 22-Nov-23 4:00 PM View: | McKelligon Brian President and CEO Director | Akoya Biosciences, Inc. (AKYA) | 20-Nov-23 | Option Exercise | 7,500 | $0.30 | $2,272.50 | 5% 152.56K to 160.06K | |
| 27-Nov-23 5:41 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 06-Nov-23 | Grant | 30,000 | -- | -- | 50% 60.55K to 90.56K | |
| 27-Nov-23 5:40 PM View: | Kamocsay Jennifer General Counsel | Akoya Biosciences, Inc. (AKYA) | 06-Nov-23 | Grant | 30,000 | -- | -- | 80% 37.5K to 67.5K | |
| 11-Sep-23 4:00 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 07-Sep-23 | Private Purchase | 20,000 | $4.60 | $92,014.30 | 49% 40.55K to 60.55K | |
| 12-Jun-23 6:18 PM View: | Lai Goldman Myla Director | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase | 20,000 | $5.00 | $100,000.00 | 100% 0 to 20.0K | |
| 12-Jun-23 6:15 PM View: | Raffin Thomas A. Director | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase | 2,020,000 | $5.00 | $10,100,000.00 | 13% 15.89M to 17.91M | |
| 12-Jun-23 6:18 PM View: | Ek John Frederick CFO | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase Duplicate | 20,000 | $5.00 | $100,000.00 | 12% 160.0K to 180.0K | |
| 12-Jun-23 6:17 PM View: | Mendel Scott Director | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase | 20,000 | $5.00 | $100,000.00 | 235% 8.5K to 28.5K | |
| 12-Jun-23 6:16 PM View: | Winkler Matthew Director | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase | 203,388 | $5.00 | $1,016,940.00 | 26% 781.13K to 984.51K | |
| 12-Jun-23 6:16 PM View: | Shepler Robert G Director | Akoya Biosciences, Inc. (AKYA) | 12-Jun-23 | Private Purchase | 120,000 | $5.00 | $600,000.00 | 48% 249.59K to 369.59K | |
| 27-Mar-23 8:07 PM View: | Pla Frederic Chief Operating Officer | Akoya Biosciences, Inc. (AKYA) | 23-Mar-23 | Payment of Exercise | 1,945 | $7.69 | $14,957.00 | (5%) 42.5K to 40.55K | |
| 27-Mar-23 8:09 PM View: | Ramachandran Niro Ph.D Chief Business Officer | Akoya Biosciences, Inc. (AKYA) | 23-Mar-23 | Payment of Exercise | 1,945 | $7.69 | $14,957.00 | (1%) 179.18K to 177.24K | |
| 27-Mar-23 8:05 PM View: | McKelligon Brian President/CEO Director | Akoya Biosciences, Inc. (AKYA) | 23-Mar-23 | Payment of Exercise | 7,437 | $7.69 | $57,190.50 | (5%) 160.0K to 152.56K | |
| 21-Mar-23 5:55 PM View: | Kamocsay Jennifer General Counsel | Akoya Biosciences, Inc. (AKYA) | 20-Mar-23 | Grant | 37,500 | -- | -- | 100% 0 to 37.5K | |
| 21-Mar-23 5:51 PM View: | Ek John Frederick Chief Financial Officer | Akoya Biosciences, Inc. (AKYA) | 20-Mar-23 | Grant | 160,000 | -- | -- | 100% 0 to 160.0K | |
| 16-Mar-23 10:00 PM View: | McKelligon Brian President/CEO Director | Akoya Biosciences, Inc. (AKYA) | 14-Mar-23 | Option Exercise | 5,000 | $0.30 | $1,515.00 | 3% 160.0K to 165.0K | |
| 16-Mar-23 10:00 PM View: | McKelligon Brian President/CEO Director | Akoya Biosciences, Inc. (AKYA) | 14-Mar-23 | Planned Option Sale | 5,000 | $9.17 | $45,852.00 | (3%) 165.0K to 160.0K | |
| 27-Feb-23 4:57 PM View: | Moy Marilee Chief People Officer | Akoya Biosciences, Inc. (AKYA) | 23-Feb-23 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 27-Feb-23 5:05 PM View: | Ramachandran Niro Ph.D Chief Business Officer | Akoya Biosciences, Inc. (AKYA) | 23-Feb-23 | Grant | 22,500 | -- | -- | 14% 156.68K to 179.18K |
